482
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

An evaluation of cabotegravir for HIV treatment and prevention

& ORCID Icon
Pages 403-414 | Received 14 Feb 2020, Accepted 26 Oct 2020, Published online: 11 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Elahe Taki, Faezeh Soleimani, Arezoo Asadi, Hossein Ghahramanpour, Ali Namvar & Mohsen Heidary. (2022) Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV. Expert Review of Anti-infective Therapy 20:8, pages 1135-1147.
Read now

Articles from other publishers (4)

S.R. Krishna Murthy Kasa, Muvvala Venkatanarayana, Lakshmi Narayana Chennuru, B. Chandra Sekhara Rao, Manohar Vemparala, Abdul Fareed Chaman & M.V.N. Kumar Talluri. (2023) Chiral LC method development: Stereo-selective separation, characterization, and determination of cabotegravir and related RS, RR, and SS isomeric impurities on coated cellulose-based chiral stationary phase by HILIC-LC and LC-MS. Journal of Pharmaceutical and Biomedical Analysis 222, pages 115062.
Crossref
Nina T. HarawaDiane TanArleen A. Leibowitz. (2022) Disparities In Uptake Of HIV Pre-Exposure Prophylaxis Among California Medicaid Enrollees. Health Affairs 41:3, pages 360-367.
Crossref
Aditya N. Bade, Howard E. Gendelman, JoEllyn McMillan & Yutong Liu. (2021) Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue. AIDS 35:11, pages 1733-1741.
Crossref
Lidija Kovač, Martin Črnugelj, Robert Roškar, Tina Trdan Lušin & Zdenko Časar. (2021) Understanding of cabotegravir degradation through isolation and characterization of key degradation products and kinetic studies. Journal of Pharmaceutical and Biomedical Analysis 201, pages 114096.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.